Explore the retrospective, cross-sectional study describing the treatment patterns of Oral Glucose-Lowering Drugs in Asian population, using the JADE (Joint Asia Diabetes Evaluation) Register.

The video above summarizes the Real-World on T2D in Asia with JADE Register design, key results and conclusion regarding the effectiveness of SUs versus non-SUs.

The Joint Asia Diabetes Evaluation (JADE) Program is the first web-based program incorporating a comprehensive risk engine, care protocols, clinical decision and self-management support to improve ambulatory diabetes care. The aim was to validate the risk stratification system of the JADE Program using a large prospective cohort.